미네소타의 전립선암 임상 시험
전립선암 관련 연구 48개가 미네소타 내 여러 지역에서 참여자를 모집하고 있습니다.
미네소타의 도시
- Minneapolis연구 23개
- Rochester연구 22개
- Saint Paul연구 13개
- Duluth연구 7개
- Saint Cloud연구 6개
- Brooklyn Park연구 6개
- Bloomington연구 6개
- Plymouth연구 6개
공식 연구 텍스트(영어)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Sanford Joe Lueken Cancer Center, Bemidji
- Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud
피험자 모집 중3상
18세 이상 · 남성 · 2026. 10. 2. 업데이트됨 · NCT06931340Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud
피험자 모집 중3상
18세 이상 · 남성 · 2026. 10. 2. 업데이트됨 · NCT07200830Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Riverwood Healthcare Center, Aitkin
- Mayo Clinic Health System in Albert Lea, Albert Lea
- Essentia Health - Baxter Clinic, Baxter
- 외 48개
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Essentia Health Saint Joseph's Medical Center, Brainerd
- Essentia Health Cancer Center, Duluth
- Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06632977A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Health Partners Frauenshuh Cancer Center, Saint Louis Park
- Health Partners Cancer Center at Regions Hospital, Saint Paul
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06172478Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Essentia Health - Deer River Clinic, Deer River
- Essentia Health Cancer Center, Duluth
- Fairview Southdale Hospital, Edina
- 외 8개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT03866382A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- University Of Minnesota, Minneapolis
피험자 모집 중1상
18세 이상 · 남성 · 2026. 9. 28. 업데이트됨 · NCT06095089Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- M Health Fairview Clinics and Surgery Center, Minneapolis
피험자 모집 중1상
18세 이상 · 남성 · 2026. 9. 25. 업데이트됨 · NCT06801236A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Avera Cancer Institute - Marshall ( Site 0122), Marshall
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0072), Saint Louis Park
- HealthPartners Cancer Research Center-HealthPartners Cancer Center at Regions Hospital ( Site 0092), Saint Paul
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06136650A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Minnesota Oncology Hematology PA, Minneapolis
- University of Minnesota Medical Center Fairview, Minneapolis
피험자 모집 중3상
18세 이상 · 남성 · 2026. 9. 22. 업데이트됨 · NCT07213674A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Rochester
피험자 모집 중3상
18세 이상 · 남성 · 2026. 9. 18. 업데이트됨 · NCT06952803Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial
- Mayo Clinic in Rochester, Rochester
피험자 모집 중2상
18세 이상 · 남성 · 2026. 9. 18. 업데이트됨 · NCT07650240A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
- GSK Investigational Site, Rochester
피험자 모집 중1/2상
18세 이상 · 남성 · 2026. 9. 18. 업데이트됨 · NCT06990880Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
피험자 모집 중2상
18세 이상 · 남성 · 2026. 9. 17. 업데이트됨 · NCT04038502A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Mayo Clinic in Rochester, Minnesota-Mayo Clinic Comprehensive Cancer Center ( Site 0078), Rochester
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0032), Saint Louis Park
- HealthPartners Cancer Center at Regions Hospital ( Site 0052), Saint Paul
피험자 모집 중3상
18세 이상 · 남성 · 2026. 9. 17. 업데이트됨 · NCT06925737Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Mayo Clinic, Rochester
피험자 모집 중
18세 이상 · 남성 · 2026. 9. 14. 업데이트됨 · NCT06511141Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Mayo Clinic- Rochester, Rochester
피험자 모집 중3상
18세 이상 · 남성 · 2026. 9. 11. 업데이트됨 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Sanford Joe Lueken Cancer Center, Bemidji
- Essentia Health Saint Joseph's Medical Center, Brainerd
- Minnesota Oncology Hematology PA-Chaska, Chaska
- 외 16개
피험자 모집 중3상
18세 이상 · 남성 · 2026. 9. 10. 업데이트됨 · NCT05946213The Vanguard Study: Testing a New Way to Screen for Cancer
- Minneapolis VA Medical Center, Minneapolis
피험자 모집 중건강한 지원자 환영
45세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06995898Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Research Site, Minneapolis
피험자 모집 중1/2상
18세 ~ 99세 · 남성 · 2026. 8. 27. 업데이트됨 · NCT07590934A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
- Masonic Cancer Center, Minneapolis
피험자 모집 중2상
18세 이상 · 남성 · 2026. 8. 21. 업데이트됨 · NCT06844383Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Minnesota Oncology - Burnsville, Burnsville
- Minnesota Oncology Hematology PA-Chaska, Chaska
- Mercy Hospital, Coon Rapids
- 외 21개
피험자 모집 중3상
18세 이상 · 남성 · 2026. 8. 19. 업데이트됨 · NCT04423211Water Vapor Ablation for Prostate Cancer: Long-Term Registry
- Minnesota Urology, Woodbury
피험자 모집 중관찰 연구
전 연령 · 남성 · 2026. 8. 18. 업데이트됨 · NCT07455058FOG-001 in Locally Advanced or Metastatic Solid Tumors
- M Health Fairview University of Minnesota Medical Center, Minneapolis
- Mayo Clinic, Rochester
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT05919264Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- University of Minnesota Medical Center, Minneapolis
- Mayo Clinic, Rochester
피험자 모집 중1상
18세 ~ 100세 · 남성 · 2026. 8. 13. 업데이트됨 · NCT05519449Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
- Mayo Clinic Health System in Albert Lea, Albert Lea
- Mayo Clinic Health System-Mankato, Mankato
- Mayo Clinic in Rochester, Rochester
피험자 모집 중
18세 이상 · 남성 · 2026. 7. 30. 업데이트됨 · NCT06325046MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
- Mayo Clinic in Rochester, Rochester
피험자 모집 중
45세 ~ 80세 · 남성 · 2026. 7. 22. 업데이트됨 · NCT05438563Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
- Mayo Clinic in Rochester, Rochester
피험자 모집 중2상
18세 이상 · 남성 · 2026. 7. 20. 업데이트됨 · NCT06378866Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Riverwood Healthcare Center, Aitkin
- Essentia Health - Baxter Clinic, Baxter
- Essentia Health Saint Joseph's Medical Center, Brainerd
- 외 18개
피험자 모집 중3상
18세 이상 · 남성 · 2026. 7. 14. 업데이트됨 · NCT06592924A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Mayo Clinic, Rochester
피험자 모집 중1상
18세 이상 · 남성 · 2026. 7. 9. 업데이트됨 · NCT07103018Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- Minnesota Oncology Hematology, Minneapolis
피험자 모집 중1상
18세 이상 · 남성 · 2026. 7. 9. 업데이트됨 · NCT05413421Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
- University of Minnesota, Minneapolis
피험자 모집 중1상
18세 이상 · 남성 · 2026. 7. 2. 업데이트됨 · NCT07140900Integrated Cancer Repository for Cancer Research
- Riverwood Healthcare Center, Aitkin
- Essentia Health-St. Joseph's Medical Center, Brainerd
- Essentia Health - Duluth Clinic, Duluth
- 외 2개
피험자 모집 중관찰 연구건강한 지원자 환영
19세 ~ 110세 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT02012699Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
- Mayo Clinic in Rochester, Rochester
피험자 모집 중건강한 지원자 환영
18세 ~ 85세 · 모든 성별 · 2026. 6. 10. 업데이트됨 · NCT06788886Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Mayo Clinic Rochester, Rochester
피험자 모집 중4상
18세 ~ 100세 · 남성 · 2026. 6. 4. 업데이트됨 · NCT05803941A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Research Site, Rochester
피험자 모집 중1상
18세 이상 · 남성 · 2026. 5. 12. 업데이트됨 · NCT06879041Axelopran for Advanced Cancer in Patients Receiving Opioids
- HealthPartners Frauenshuh Cancer Research Center, Saint Louis Park
- HealthPartners Cancer Center at Regions Hospital, Saint Paul
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 5. 5. 업데이트됨 · NCT07354919Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI
- Mayo Clinic in Rochester, Rochester
피험자 모집 중관찰 연구건강한 지원자 환영
18세 이상 · 모든 성별 · 2026. 4. 17. 업데이트됨 · NCT06315595A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Mayo Clinic, Rochester
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 3. 27. 업데이트됨 · NCT06395519Screening and Staging of Benign vs Malignant Pelvic Abnormalities
- Mayo Clinic in Rochester, Rochester
피험자 모집 중관찰 연구건강한 지원자 환영
18세 이상 · 모든 성별 · 2026. 2. 17. 업데이트됨 · NCT07407959ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.